Notes and Quotes
Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence
Increased priming for interleukin-12 and tumour necrosis factor α in CD64 monocytes in HIV infection: modulation by cytokines and therapy
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers
Cerebrospinal fluid response to structured treatment interruption after virological failure
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine
Modelling the effect of combination antiretroviral treatments on HIV incidence
Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA
Increase in the share of steady partners as a source of HIV infection: a 17-year study of seroconversion among gay men
Calculating the consequences: HAART and risky sex
Viral levels in newborn African infants undergoing primary HIV-1 infection
Mutations of the 3′ untranslated region of the SDF1 gene in apes and monkeys: potential impact on sensitivity to AIDS induced by lentiviruses
No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia
Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis
Time trend in incidence of HIV seroconversion among homosexual men repeatedly tested in Madrid, 1988–2000
Increasing incidence of HIV infections among young gay and biseuxal men in Vancouver
Management of sudden psychiatric disorders related to efavirenz
The abacavir hypersensitivity reaction and interruptions in therapy
Reply to ‘The abacavir hypersensitivity reaction and interruptions in therapy’ by A. Edde Loeliger, Helen Steel, Sue McGuirk, Wendy S. Powell and Seth V. Hetherington
Reply to ‘Methods of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa’ by A. Coutsoudis, K. Pillay, L. Kuhn, E. Spooner, W.-Y. Tsai, H. Coovadia, for the South African Vitamin A Study Group
Mother-to-child transmission of HIV-1 and infant feeding practice